Aldeyra Therapeutics Inc (ALDX) Live Share Price, Invest From India

Aldeyra Therapeutics Inc Stock Performance

as on March 26, 2026 at 6:59 am IST

Day's Low
Day's High
$1.76
Day's Price Range
$1.99
$1.86
5.38%
Downside
6.99%
Upside
52 Week's Low
52 Week's High
$1.07
52-Week Price Range
$6.81
$1.86
42.47%
Downside
266.10%
Upside

Aldeyra Therapeutics Inc share price movements today

Previous Close: $1.87
Open: $1.97
Volume: 5.9M
Day's Low - High: $1.76 - $1.99
52 Week Low - High: $1.07 - $6.81

Aldeyra Therapeutics Inc Historical Returns

1 Month Return: -65.94 %
3 Month Return: -64.58 %
1 Year Return: -72.01 %
3 Year Return: -79.29 %
5 Year Return: -83.51 %

Aldeyra Therapeutics Inc Stock Fundamentals & Key Indicators

Check Aldeyra Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$134.2M

EPS (TTM)

-0.4033

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-35.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-58.73%

Aldeyra Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aldeyra Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aldeyra Therapeutics Inc	BUY	$134.2M	-83.51%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$40.7B	127.78%	131.61	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$114.6B	111.25%	29.42	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111.23	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.9B	60.03%	17.76	31.41%

Stock Returns calculator for Aldeyra Therapeutics Inc Stock including INR - Dollar returns

The Aldeyra Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Aldeyra Therapeutics Inc investment value today

Current value as on today

₹37,805

Returns

₹62,195

(-62.19%)

Returns from Aldeyra Therapeutics Inc Stock

₹72,156 (-72.16%)

Dollar Returns*

₹9,961 (+9.96%)

Analyst Recommendation on Aldeyra Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Aldeyra Therapeutics Inc. Average target price of $7.5

Aldeyra Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Aldeyra Therapeutics Inc.

What analysts predicted

75.2%UPSIDE

Target Price

$7.5

Current Price

$1.86

Analyzed by

14 Analysts

Target

$7.50

Aldeyra Therapeutics Inc target price $7.5, a slight upside of 75.2% compared to current price of $1.86. According to 14 analysts rating.

Aldeyra Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Aldeyra Therapeutics Inc Shares on INDmoney has grown by 5500.00% over the past 30 days, indicating increased transactional activity.

Time period: February 24, 2026 to March 26, 2026

Change:5500.00% versus previous 30 day period

Search interest for Aldeyra Therapeutics Inc Stock has increased by 1853% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 24, 2026 to March 26, 2026

Change:1853% versus previous 30 day period

Aldeyra Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-9	-6	-9	-18	-16	-16	-10	-10	-8	-6
EBITDA	-7	-4	-7	-16	-14	-15	-9	-9	-7	1,085,382
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-4	-8	-16	-15	-15	-9	-9	-7	-6
Income Tax Expense	1	-3	0	0	-	0	-	-	-	-
Net Income	-8	-4	-8	-16	-15	-15	-9	-9	-7	-6
Net Profit Margin	0.00%	-1210.58%	0.00%	0.00%	0.00%	-6465.07%	0.00%	0.00%	0.00%	0.00%

Aldeyra Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-18	-22	-39	-63	-34	-56	-62	-42	-60	-35
EBITDA	-18	-22	-38	-61	-36	-55	-60	-35	-53	-31
Interest Expense	0	0	0	0	1	1	1	2	1	1
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-18	-22	-38	-62	-38	-57	-62	-37	-55	-33
Income Tax Expense	0	0	0	-1	0	1	0	-	-55,851,444	-
Net Income	-18	-22	-38	-60	-37	-57	-62	-37	-55	-33
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Aldeyra Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-4	-8	-16	-15	-15	-9	-9	-7	23,164,777
Operating Cash Flow	0	-9	-13	-7	-12	-12	-8	-7	-5
Investing Cash Flow	-	-30	-18	5	-1	7	0	25	16
Financing Cash Flow	-1	0	-	0	0	1	1,002,808	0	-2,005,617
Change in Cash	0	-90	-21	-2	-13	-4	-9	18	10

Aldeyra Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-22	-38	-60	-37	-57	-62	-37	-55	-33,846,661
Operating Cash Flow	-19	-29	-44	-37	-42	-56	-30	-43	-33,345,682
Investing Cash Flow	-10	-23	18	29	0	-29	30	-44	47,736,288
Financing Cash Flow	37	80	23	41	194	1	-1	0	1,123,556
Change in Cash	8	27	-2	33	151	-85	-1	-88	15,514,162

Global Institutional Holdings in Aldeyra Therapeutics Inc

Funds	Holdings
683 Capital Management LLC	2.54%
Deutsche Bank AG	0.51%
Geode Capital Management, LLC	1.95%
Wells Fargo & Co	0.6%
Northern Trust Corp	0.68%

See all

Insights on Aldeyra Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ALDX stock has moved up by 31.7%
NO EFFECT
Against Peers
In the last 3 years, Aldeyra Therapeutics Inc has experienced a drawdown of -79.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 69.8%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 17.0% return, outperforming this stock by 89.0%

About Aldeyra Therapeutics Inc

dedicated to improving lives by developing products that treat aldehyde-mediated diseases. we are a biotechnology company focused primarily on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes. we are developing adx-102 (formerly ns2), as well as other novel product candidates that are designed specifically to sequester aldehydes, for the treatment of: • noninfectious anterior uveitis, a rare severe inflammatory eye disease that can lead to blindness; • allergic conjunctivitis, a common disease that affects more than 20% of the population worldwide, and related rare allergic ocular diseases that are characterized by inflammation of the conjunctiva (a membrane covering part of the front of the eye), resulting in ocular itching, excessive tear production, swelling, and redness; • dry eye disease, a common inflammatory dise

Organisation	Aldeyra Therapeutics Inc
Headquarters	131 Hartwell Avenue, Lexington, MA, United States, 02421
Industry	Health Technology
CEO	Dr. Todd C. Brady M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Aldeyra Therapeutics Inc

Name	Title
Laura Nichols	Operations Manager
Dr. Adam Lazorchak	Director of Translational Sciences & Non-Clinical Development
Dr. Todd C. Brady M.D., Ph.D.	CEO, President & Director
Mr. Michael Alfieri	Head of Finance and Principal Financial & Accounting Officer
Dr. Stephen G. Machatha Ph.D.	Chief Development Officer
David Burke	Head of Investor Relations

FAQs

What is Aldeyra Therapeutics Inc share price today?

Aldeyra Therapeutics Inc share price today is $1.86 as on March 26, 2026 at 1:29 am IST at the close of the market. Aldeyra Therapeutics Inc share today touched a day high of $1.99 and a low of $1.76.

What is the 52 week high and 52 week low for Aldeyra Therapeutics Inc share?

Aldeyra Therapeutics Inc share touched a 52 week high of $6.81 on March 25, 2025 and a 52 week low of $1.07 on March 17, 2026. Aldeyra Therapeutics Inc stock price today i.e. March 26, 2026 at 1:29 am IST is closed at $1.86,which is 72.68% down from its 52 week high and 73.83% up from its 52 week low.

What is Aldeyra Therapeutics Inc's market capitalisation today?

Aldeyra Therapeutics Inc market capitalisation is $0.00T as on March 26, 2026 at 1:29 am IST.

How to invest in Aldeyra Therapeutics Inc Stock (ALDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aldeyra Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aldeyra Therapeutics Inc Shares that will get you 0.8065 shares as per Aldeyra Therapeutics Inc share price of $1.86 per share as on March 26, 2026 at 1:29 am IST.

What is the minimum amount required to buy Aldeyra Therapeutics Inc Stock (ALDX) from India?

Indian investors can start investing in Aldeyra Therapeutics Inc (ALDX) shares with as little as ₹94.138 or $1 (as of March 26, 2026 at 3:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹941.38 in Aldeyra Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on March 26, 2026 at 3:38 am IST). Based on Aldeyra Therapeutics Inc share’s latest price of $1.86 as on March 26, 2026 at 1:29 am IST, you will get 5.3763 shares of Aldeyra Therapeutics Inc. Learn more about fractional shares .

What are the returns that Aldeyra Therapeutics Inc has given to Indian investors in the last 5 years?

Aldeyra Therapeutics Inc stock has given -83.51% share price returns and 28.28% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?